» Articles » PMID: 2355013

Purification and Characterization of Canine Myocardial Cytosolic Phospholipase A2. A Calcium-independent Phospholipase with Absolute F1-2 Regiospecificity for Diradyl Glycerophospholipids

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1990 Jun 25
PMID 2355013
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, we identified a novel calcium-independent, plasmalogen-selective phospholipase A2 activity in canine myocardial cytosol which represents the major measurable phospholipase A2 activity in myocardial homogenates (Wolf, R. A., and Gross, R. W. (1985) J. Biol. Chem. 260, 7295-7303). We now report the 154,000-fold purification of this phospholipase A2 to homogeneity through utilization of sequential anion exchange, chromatofocusing, affinity, Mono Q, and hydroxylapatite chromatographies. The purified enzyme had a molecular mass of 40 kDa, possessed a specific activity of 227 mumol/mg min, had a pH optimum of 6.4, and catalyzed the regiospecific cleavage of the sn-2 fatty acid from diradyl glycerophospholipids. The purified polypeptide was remarkable for its ability to selectively hydrolyze plasmenylcholine in homogeneous vesicles (subclass rank order: plasmenylcholine greater than alkyl-ether choline glycerophospholipid greater than phosphatidylcholine) as well as in mixed bilayers comprised of equimolar plasmenylcholine/phosphatidylcholine. Purified myocardial phospholipase A2 also possessed selectivity for hydrolysis of phospholipids containing arachidonic acid at the sn-2 position in comparison to oleic or palmitic acid. Taken together, these results constitute the first purification of a calcium-independent phospholipase with absolute regiospecificity for cleavage of the sn-2 acyl linkage in diradyl glycerophospholipids and demonstrate that myocardial phospholipase A2 has kinetic characteristics which are anticipated to result in the selective hydrolysis of sarcolemmal phospholipids during myocardial ischemia.

Citing Articles

Noncanonical Regulation of cAMP-Dependent Insulin Secretion and Its Implications in Type 2 Diabetes.

Ramanadham S, Turk J, Bhatnagar S Compr Physiol. 2023; 13(3):5023-5049.

PMID: 37358504 PMC: 10809800. DOI: 10.1002/cphy.c220031.


Regulation of plasmalogen metabolism and traffic in mammals: The fog begins to lift.

Dorninger F, Werner E, Berger J, Watschinger K Front Cell Dev Biol. 2022; 10:946393.

PMID: 36120579 PMC: 9471318. DOI: 10.3389/fcell.2022.946393.


Current Knowledge on Mammalian Phospholipase A, Brief History, Structures, Biochemical and Pathophysiological Roles.

Yaginuma S, Kawana H, Aoki J Molecules. 2022; 27(8).

PMID: 35458682 PMC: 9031518. DOI: 10.3390/molecules27082487.


The foundations and development of lipidomics.

Han X, Gross R J Lipid Res. 2021; 63(2):100164.

PMID: 34953866 PMC: 8953652. DOI: 10.1016/j.jlr.2021.100164.


Plasmalogen Replacement Therapy.

Bozelli Jr J, Epand R Membranes (Basel). 2021; 11(11).

PMID: 34832067 PMC: 8620983. DOI: 10.3390/membranes11110838.